Lighthouse Investment Partners LLC Has $468,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lighthouse Investment Partners LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 84.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,000 shares of the company’s stock after selling 33,277 shares during the period. Lighthouse Investment Partners LLC’s holdings in GE HealthCare Technologies were worth $468,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of GEHC. Global Assets Advisory LLC acquired a new position in shares of GE HealthCare Technologies during the first quarter worth about $4,273,000. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after acquiring an additional 4,107,746 shares in the last quarter. Mather Group LLC. acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at approximately $106,000. Bank of Montreal Can lifted its position in shares of GE HealthCare Technologies by 27.5% in the second quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock worth $54,964,000 after purchasing an additional 150,137 shares in the last quarter. Finally, Sei Investments Co. boosted its holdings in GE HealthCare Technologies by 30.6% during the first quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock worth $25,393,000 after purchasing an additional 65,476 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $91.99 on Monday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $41.99 billion, a P/E ratio of 26.90, a P/E/G ratio of 3.40 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The stock has a 50 day moving average of $85.13 and a 200-day moving average of $83.22.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The firm had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company earned $0.92 earnings per share. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the company from $84.00 to $74.00 in a research report on Thursday. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Stifel Nicolaus began coverage on GE HealthCare Technologies in a research report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price target on the stock. Finally, BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $93.92.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.